Intravenous nicotine self-administration in rats: effects of mecamylamine, hexamethonium and naloxone
The rate and pattern of lever pressing were studied in 18 rats during 24-h sessions in which responding resulted in intravenous infusions of nicotine. There were four indications of the positive reinforcing effect of nicotine: (1) a greater number of lever presses when nicotine was response-continge...
Gespeichert in:
Veröffentlicht in: | Psychopharmacology 2006-02, Vol.184 (3-4), p.266-272 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 272 |
---|---|
container_issue | 3-4 |
container_start_page | 266 |
container_title | Psychopharmacology |
container_volume | 184 |
creator | DeNoble, Victor J Mele, Paul C |
description | The rate and pattern of lever pressing were studied in 18 rats during 24-h sessions in which responding resulted in intravenous infusions of nicotine. There were four indications of the positive reinforcing effect of nicotine: (1) a greater number of lever presses when nicotine was response-contingent compared to when saline was available; (2) a greater number of responses on the lever resulting in an infusion of nicotine than on the control lever; (3) systematic decreases in the number of contingent nicotine infusions when nicotine was delivered noncontingently; and (4) systematic changes in the frequency of lever pressing as a function of dose. Under a fixed ratio 1 (FR 1) schedule, the number of infusions first increased and then decreased as the dose of nicotine was decreased (64, 32, 16, and 8 microg/kg infusion) and nicotine intake (mg/kg every 24 h) was directly related to the infusion dose. As the FR size was increased from 1 to 6, the number of lever presses increased and the number of infusions (32 microg/kg) remained stable. At FR values greater than 6, both the number of lever presses and infusions decreased. Presession injections of mecamylamine (0.75, 1.5, and 3.0 mg/kg, s.c.) decreased the number of infusions in a dose-related manner. Presession injections of hexamethonium (1.5 and 3.0 mg/kg, s.c.) or naloxone (0.75, 1.5, and 3.0 mg/kg, s.c.) did not alter the within- or between-session patterns of nicotine self-administration. Under the conditions of the present experiment, nicotine served as an effective reinforcer and the behavior was shown to be sensitive to both FR size and infusion dose. In addition, the results suggest that nicotine self-administration involves central nicotinic receptors and that opioid receptor antagonism has no effect on nicotine's reinforcing effects in rats. |
doi_str_mv | 10.1007/s00213-005-0054-z |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_754557664</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1440233451</sourcerecordid><originalsourceid>FETCH-LOGICAL-c389t-514c6ee204a1a738128dfb1573541431500930699d5710ee435a9a373225d91d3</originalsourceid><addsrcrecordid>eNqFkU9LHjEQxoNU9K36AXopoYf24upM_uwm3opYFQQveg5xdxYju4nd7Bb105uX94VCD3VgmIH5zQMzD2NfEE4QoDnNAAJlBaDXqaq3HbZCJUUloBGf2ApAykqiNvvsc85PUEIZtcf2sQZjFMoVo-s4T_4PxbRkHkOb5hCJZxr6yndjiCGX8RxS5CHy0uUzTn1P7Zx56vlIrR9fB19AOuaP9OJHmh9TDMvIfex49EN6SZEO2W7vh0xH23rA7n9d3J1fVTe3l9fnP2-qVho7VxpVWxMJUB59Iw0K0_UPqBupVbkLNYCVUFvb6QaBSEntrZeNFEJ3Fjt5wH5sdJ-n9HuhPLsx5JaGwUcqB7pGK62bulaF_P5fsi6UEYgfgmiFUdrWBfz2D_iUlql8IDuBxtZoFBQIN1A7pZwn6t3zFEY_vToEt_bUbTx1xc91KvdWdr5uhZeHkbq_G1sT5Tt7NJuF</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>218961840</pqid></control><display><type>article</type><title>Intravenous nicotine self-administration in rats: effects of mecamylamine, hexamethonium and naloxone</title><source>MEDLINE</source><source>SpringerLink Journals</source><creator>DeNoble, Victor J ; Mele, Paul C</creator><creatorcontrib>DeNoble, Victor J ; Mele, Paul C</creatorcontrib><description>The rate and pattern of lever pressing were studied in 18 rats during 24-h sessions in which responding resulted in intravenous infusions of nicotine. There were four indications of the positive reinforcing effect of nicotine: (1) a greater number of lever presses when nicotine was response-contingent compared to when saline was available; (2) a greater number of responses on the lever resulting in an infusion of nicotine than on the control lever; (3) systematic decreases in the number of contingent nicotine infusions when nicotine was delivered noncontingently; and (4) systematic changes in the frequency of lever pressing as a function of dose. Under a fixed ratio 1 (FR 1) schedule, the number of infusions first increased and then decreased as the dose of nicotine was decreased (64, 32, 16, and 8 microg/kg infusion) and nicotine intake (mg/kg every 24 h) was directly related to the infusion dose. As the FR size was increased from 1 to 6, the number of lever presses increased and the number of infusions (32 microg/kg) remained stable. At FR values greater than 6, both the number of lever presses and infusions decreased. Presession injections of mecamylamine (0.75, 1.5, and 3.0 mg/kg, s.c.) decreased the number of infusions in a dose-related manner. Presession injections of hexamethonium (1.5 and 3.0 mg/kg, s.c.) or naloxone (0.75, 1.5, and 3.0 mg/kg, s.c.) did not alter the within- or between-session patterns of nicotine self-administration. Under the conditions of the present experiment, nicotine served as an effective reinforcer and the behavior was shown to be sensitive to both FR size and infusion dose. In addition, the results suggest that nicotine self-administration involves central nicotinic receptors and that opioid receptor antagonism has no effect on nicotine's reinforcing effects in rats.</description><identifier>ISSN: 0033-3158</identifier><identifier>EISSN: 1432-2072</identifier><identifier>DOI: 10.1007/s00213-005-0054-z</identifier><identifier>PMID: 16088413</identifier><language>eng</language><publisher>Germany: Springer Nature B.V</publisher><subject>Animals ; Association Learning - drug effects ; Brain - drug effects ; Catheters ; Conditioning, Operant - drug effects ; Disease Models, Animal ; Dose-Response Relationship, Drug ; Drug dosages ; Food ; Hexamethonium - pharmacology ; Humans ; Infusion pumps ; Infusions, Intravenous ; Male ; Mecamylamine - pharmacology ; Naloxone - pharmacology ; Nicotine ; Nicotine - administration & dosage ; Nicotinic Antagonists - pharmacology ; Psychopharmacology ; Rats ; Rats, Long-Evans ; Receptors, Nicotinic - drug effects ; Receptors, Opioid - drug effects ; Reinforcement Schedule ; Schedules</subject><ispartof>Psychopharmacology, 2006-02, Vol.184 (3-4), p.266-272</ispartof><rights>Springer-Verlag 2006</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c389t-514c6ee204a1a738128dfb1573541431500930699d5710ee435a9a373225d91d3</citedby><cites>FETCH-LOGICAL-c389t-514c6ee204a1a738128dfb1573541431500930699d5710ee435a9a373225d91d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16088413$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>DeNoble, Victor J</creatorcontrib><creatorcontrib>Mele, Paul C</creatorcontrib><title>Intravenous nicotine self-administration in rats: effects of mecamylamine, hexamethonium and naloxone</title><title>Psychopharmacology</title><addtitle>Psychopharmacology (Berl)</addtitle><description>The rate and pattern of lever pressing were studied in 18 rats during 24-h sessions in which responding resulted in intravenous infusions of nicotine. There were four indications of the positive reinforcing effect of nicotine: (1) a greater number of lever presses when nicotine was response-contingent compared to when saline was available; (2) a greater number of responses on the lever resulting in an infusion of nicotine than on the control lever; (3) systematic decreases in the number of contingent nicotine infusions when nicotine was delivered noncontingently; and (4) systematic changes in the frequency of lever pressing as a function of dose. Under a fixed ratio 1 (FR 1) schedule, the number of infusions first increased and then decreased as the dose of nicotine was decreased (64, 32, 16, and 8 microg/kg infusion) and nicotine intake (mg/kg every 24 h) was directly related to the infusion dose. As the FR size was increased from 1 to 6, the number of lever presses increased and the number of infusions (32 microg/kg) remained stable. At FR values greater than 6, both the number of lever presses and infusions decreased. Presession injections of mecamylamine (0.75, 1.5, and 3.0 mg/kg, s.c.) decreased the number of infusions in a dose-related manner. Presession injections of hexamethonium (1.5 and 3.0 mg/kg, s.c.) or naloxone (0.75, 1.5, and 3.0 mg/kg, s.c.) did not alter the within- or between-session patterns of nicotine self-administration. Under the conditions of the present experiment, nicotine served as an effective reinforcer and the behavior was shown to be sensitive to both FR size and infusion dose. In addition, the results suggest that nicotine self-administration involves central nicotinic receptors and that opioid receptor antagonism has no effect on nicotine's reinforcing effects in rats.</description><subject>Animals</subject><subject>Association Learning - drug effects</subject><subject>Brain - drug effects</subject><subject>Catheters</subject><subject>Conditioning, Operant - drug effects</subject><subject>Disease Models, Animal</subject><subject>Dose-Response Relationship, Drug</subject><subject>Drug dosages</subject><subject>Food</subject><subject>Hexamethonium - pharmacology</subject><subject>Humans</subject><subject>Infusion pumps</subject><subject>Infusions, Intravenous</subject><subject>Male</subject><subject>Mecamylamine - pharmacology</subject><subject>Naloxone - pharmacology</subject><subject>Nicotine</subject><subject>Nicotine - administration & dosage</subject><subject>Nicotinic Antagonists - pharmacology</subject><subject>Psychopharmacology</subject><subject>Rats</subject><subject>Rats, Long-Evans</subject><subject>Receptors, Nicotinic - drug effects</subject><subject>Receptors, Opioid - drug effects</subject><subject>Reinforcement Schedule</subject><subject>Schedules</subject><issn>0033-3158</issn><issn>1432-2072</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNqFkU9LHjEQxoNU9K36AXopoYf24upM_uwm3opYFQQveg5xdxYju4nd7Bb105uX94VCD3VgmIH5zQMzD2NfEE4QoDnNAAJlBaDXqaq3HbZCJUUloBGf2ApAykqiNvvsc85PUEIZtcf2sQZjFMoVo-s4T_4PxbRkHkOb5hCJZxr6yndjiCGX8RxS5CHy0uUzTn1P7Zx56vlIrR9fB19AOuaP9OJHmh9TDMvIfex49EN6SZEO2W7vh0xH23rA7n9d3J1fVTe3l9fnP2-qVho7VxpVWxMJUB59Iw0K0_UPqBupVbkLNYCVUFvb6QaBSEntrZeNFEJ3Fjt5wH5sdJ-n9HuhPLsx5JaGwUcqB7pGK62bulaF_P5fsi6UEYgfgmiFUdrWBfz2D_iUlql8IDuBxtZoFBQIN1A7pZwn6t3zFEY_vToEt_bUbTx1xc91KvdWdr5uhZeHkbq_G1sT5Tt7NJuF</recordid><startdate>20060201</startdate><enddate>20060201</enddate><creator>DeNoble, Victor J</creator><creator>Mele, Paul C</creator><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QG</scope><scope>7QR</scope><scope>7RV</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>8AO</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20060201</creationdate><title>Intravenous nicotine self-administration in rats: effects of mecamylamine, hexamethonium and naloxone</title><author>DeNoble, Victor J ; Mele, Paul C</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c389t-514c6ee204a1a738128dfb1573541431500930699d5710ee435a9a373225d91d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Animals</topic><topic>Association Learning - drug effects</topic><topic>Brain - drug effects</topic><topic>Catheters</topic><topic>Conditioning, Operant - drug effects</topic><topic>Disease Models, Animal</topic><topic>Dose-Response Relationship, Drug</topic><topic>Drug dosages</topic><topic>Food</topic><topic>Hexamethonium - pharmacology</topic><topic>Humans</topic><topic>Infusion pumps</topic><topic>Infusions, Intravenous</topic><topic>Male</topic><topic>Mecamylamine - pharmacology</topic><topic>Naloxone - pharmacology</topic><topic>Nicotine</topic><topic>Nicotine - administration & dosage</topic><topic>Nicotinic Antagonists - pharmacology</topic><topic>Psychopharmacology</topic><topic>Rats</topic><topic>Rats, Long-Evans</topic><topic>Receptors, Nicotinic - drug effects</topic><topic>Receptors, Opioid - drug effects</topic><topic>Reinforcement Schedule</topic><topic>Schedules</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>DeNoble, Victor J</creatorcontrib><creatorcontrib>Mele, Paul C</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Nursing & Allied Health Database</collection><collection>Neurosciences Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest Psychology</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Psychopharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>DeNoble, Victor J</au><au>Mele, Paul C</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Intravenous nicotine self-administration in rats: effects of mecamylamine, hexamethonium and naloxone</atitle><jtitle>Psychopharmacology</jtitle><addtitle>Psychopharmacology (Berl)</addtitle><date>2006-02-01</date><risdate>2006</risdate><volume>184</volume><issue>3-4</issue><spage>266</spage><epage>272</epage><pages>266-272</pages><issn>0033-3158</issn><eissn>1432-2072</eissn><abstract>The rate and pattern of lever pressing were studied in 18 rats during 24-h sessions in which responding resulted in intravenous infusions of nicotine. There were four indications of the positive reinforcing effect of nicotine: (1) a greater number of lever presses when nicotine was response-contingent compared to when saline was available; (2) a greater number of responses on the lever resulting in an infusion of nicotine than on the control lever; (3) systematic decreases in the number of contingent nicotine infusions when nicotine was delivered noncontingently; and (4) systematic changes in the frequency of lever pressing as a function of dose. Under a fixed ratio 1 (FR 1) schedule, the number of infusions first increased and then decreased as the dose of nicotine was decreased (64, 32, 16, and 8 microg/kg infusion) and nicotine intake (mg/kg every 24 h) was directly related to the infusion dose. As the FR size was increased from 1 to 6, the number of lever presses increased and the number of infusions (32 microg/kg) remained stable. At FR values greater than 6, both the number of lever presses and infusions decreased. Presession injections of mecamylamine (0.75, 1.5, and 3.0 mg/kg, s.c.) decreased the number of infusions in a dose-related manner. Presession injections of hexamethonium (1.5 and 3.0 mg/kg, s.c.) or naloxone (0.75, 1.5, and 3.0 mg/kg, s.c.) did not alter the within- or between-session patterns of nicotine self-administration. Under the conditions of the present experiment, nicotine served as an effective reinforcer and the behavior was shown to be sensitive to both FR size and infusion dose. In addition, the results suggest that nicotine self-administration involves central nicotinic receptors and that opioid receptor antagonism has no effect on nicotine's reinforcing effects in rats.</abstract><cop>Germany</cop><pub>Springer Nature B.V</pub><pmid>16088413</pmid><doi>10.1007/s00213-005-0054-z</doi><tpages>7</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0033-3158 |
ispartof | Psychopharmacology, 2006-02, Vol.184 (3-4), p.266-272 |
issn | 0033-3158 1432-2072 |
language | eng |
recordid | cdi_proquest_miscellaneous_754557664 |
source | MEDLINE; SpringerLink Journals |
subjects | Animals Association Learning - drug effects Brain - drug effects Catheters Conditioning, Operant - drug effects Disease Models, Animal Dose-Response Relationship, Drug Drug dosages Food Hexamethonium - pharmacology Humans Infusion pumps Infusions, Intravenous Male Mecamylamine - pharmacology Naloxone - pharmacology Nicotine Nicotine - administration & dosage Nicotinic Antagonists - pharmacology Psychopharmacology Rats Rats, Long-Evans Receptors, Nicotinic - drug effects Receptors, Opioid - drug effects Reinforcement Schedule Schedules |
title | Intravenous nicotine self-administration in rats: effects of mecamylamine, hexamethonium and naloxone |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T22%3A04%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Intravenous%20nicotine%20self-administration%20in%20rats:%20effects%20of%20mecamylamine,%20hexamethonium%20and%20naloxone&rft.jtitle=Psychopharmacology&rft.au=DeNoble,%20Victor%20J&rft.date=2006-02-01&rft.volume=184&rft.issue=3-4&rft.spage=266&rft.epage=272&rft.pages=266-272&rft.issn=0033-3158&rft.eissn=1432-2072&rft_id=info:doi/10.1007/s00213-005-0054-z&rft_dat=%3Cproquest_cross%3E1440233451%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=218961840&rft_id=info:pmid/16088413&rfr_iscdi=true |